
Board Meeting17 Oct 2026, 07:10 pm
Hemo Organic Ltd Board Approves Un-audited Financial Results
AI Summary
Hemo Organic Ltd announced that its Board of Directors met on October 17, 2026, to approve and take on record the un-audited standalone financial results for the quarter and half-year ended September 30, 2026. The meeting also included a review of the limited review report from the statutory auditors. Other routine business as per the agenda was also transacted. The company operates in a single segment, and disclosures under Ind AS 108 are not applicable.
Key Highlights
- Board meeting held on October 17, 2026.
- Approved un-audited standalone financial results for Q2 FY27.
- Limited review report from statutory auditors taken on record.
- Company operates in a single business segment.
Price Impact
More from HEMORGANIC